Medindia1mon
Akeso's Cadonilimab Receives Second Indication Approval from NMPA for First-Line Treatment of Gastric/GEJ Cancer in All-Comers Population
Beyond first-line approval, the phase III clinical study (AK109-301) of cadonilimab combined with pulocimab (AK109, VEGFR-2) for treating advanced gastric cancer that has progressed after PD-1/L1 ...
Wall Street Journal2d
Sabine Royalty Trust UBI
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Nasdaq4y
Sabine Royalty Trust Common Stock (SBR) Dividend History
The Dividend History page provides a single page to review all of the aggregated Dividend payment information. Visit our Dividend Calendar: Please note that the dividend history for Nasdaq stocks ...
Benzinga.com4y
Sabine Royalty (NYSE:SBR) Stock Quotes, Forecast and News Summary
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Applied Therapeutics, Inc. Avi Kapoor Passive Income Ideas For ...